Full Professor(heuristic)

Monoclonal and Polyclonal Antibodies Research · Radiology, Nuclear Medicine and Imaging

Compare more Radiology, Nuclear Medicine and Imaging professors.

h-index56
i10-index115
Publications229
Citations15,779

Grants

9 total · 2 active

NIH #R00HL161472

The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias

Active
Amount
$200K–$300K
Period
2025-04-18 → 2028-03-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NSF #2515792

Causal Inference in the Presence of Interference for Randomized Experiments

Active
Amount
$100K–$200K
Period
2025-09-01 → 2027-08-31
PIs
1

Awarded at Carnegie Mellon University

NIH #R21DE033901

Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögren’s and SICCA Syndromes

Amount
$200K–$300K
Period
2024-09-16 → 2026-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

9 total · 2 active

NIH #R00HL161472

The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias

Active
Amount
$200K–$300K
Period
2025-04-18 → 2028-03-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NSF #2515792

Causal Inference in the Presence of Interference for Randomized Experiments

Active
Amount
$100K–$200K
Period
2025-09-01 → 2027-08-31
PIs
1

Awarded at Carnegie Mellon University

NIH #R21DE033901

Saliva Anti-SSA/Ro and Anti-SSB/La for Early Detection of Sjögren’s and SICCA Syndromes

Amount
$200K–$300K
Period
2024-09-16 → 2026-08-31
PIs
3

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #K99HL161472

The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias

Amount
$100K–$200K
Period
2022-08-01 → 2025-01-31
PIs
1

Awarded at BRIGHAM AND WOMEN'S HOSPITAL

NIH #UH3CA206126

Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients

Amount
$300K–$400K
Period
2017-03-06 → 2022-02-28
PIs
4

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #UH2CA206126

Advancing EFIRM-Liquid Biopsy (eLB) to a CLIA-Certified Laboratory Developed Test (eLB-LDT) for Detection of Actionable EGFR Mutations in NSCLC Patients

Amount
$100K–$200K
Period
2017-03-06 → 2019-02-28
PIs
5

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #N1CN25404A

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER SCREENING TRIAL - LABORA

Amount
$1M–$2M
Period
1992-09-30 → 2008-09-29
PIs
1

NIH #N01CN025404

PROSTATE, LUNG, COLORECTAL, AND OVARIAN (PLCO) CANCER

Amount
$500K–$600K
Period
1992-09-30 → 2006-09-29
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

NIH #U24CA086366

BIOMARKERS VALIDATION LABORATORIES

Amount
$700K–$800K
Period
2000-05-16 → 2005-07-31
PIs
1

Awarded at UNIVERSITY OF CALIFORNIA LOS ANGELES

Recent Public Signals

  1. New NSF award: Causal Inference in the Presence of Interference for Randomized Experiments2025-09-01
  2. New paper: Microtubule Acetylation Contributes to Myofibroblast Activation in Lung Fibrosis (American Journal of Respiratory and Critical Care Medicine)2025-05-01
  3. New NIH award: The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias2025-04-18

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-01

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0002-0723-3670

Professor Insights

Career Trajectory